Ethan Perlstein Overview

  • Investor Type
  • Angel
  • Investments
  • 3
  • Portfolio
  • 2

Ethan Perlstein General Information

Description

Dr. Ethan Perlstein is a Co-Founder of Perlara and serves as its Chief Executive Officer and Board Member. He is a graduate of Harvard University in the Department of Molecular and Cell Biology with a PhD. He developed an approach to studying old drugs and discovering new drugs in model organisms called evolutionary pharmacology. He is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 6000 Shoreline Court
  • Suite 204
  • South San Francisco, CA 94080
  • United States
+1 (617) 000-0000

Ethan Perlstein Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Osmind 03-Sep-2020 Seed Round 000 Other Healthcare Technology Systems Generating Revenue
00000000 000 25-Jul-2017 00000 00000 00.000 Pharmaceuticals Generating Revenue 00000 000000000 00.0
00000000 000 29-Jun-2015 000000000000 00000 Pharmaceuticals Generating Revenue 00000 000000000 00.0
To view Ethan Perlstein’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ethan Perlstein Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Ethan Perlstein Team (1)

Name Title Deals Funds Boards Office
Ethan Perlstein Ph.D Angel Investor 0 0 South San Francisco, CA
To view Ethan Perlstein’s complete team members history, request access »

Ethan Perlstein Co-Investors (20)

Name With Exits Lead Partner Series Industry
Anges Québec 1 0 Series chart Industry bar
GC Innovation America 0 Series chart Industry bar
General Catalyst 0 Series chart Industry bar
Pear 0 Series chart Industry bar
SOSV 0 0 Series chart Industry bar
You’re viewing 5 of 20 co-investors. Get the full list »